Predictive value of clinical judgment of tumour progression in phase II trials.

<h4>Background</h4>The diagnosis of tumour progression or progressive disease (PD) is a key element for designing and interpreting contemporary phase II trials. In some cases, PD is stated by the physician and is not formally confirmed by imaging.<h4>Purpose</h4>In this study...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nuria Kotecki, Nicolas Penel, Antoine Adenis, Charles Ferte, Stéphanie Clisant
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3863f9b65184415893c32d5361af0b0c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!